PALI Palisade Bio, Inc. Common Stock : Bullish and Bearish Analyst Opinions
Sentiment & Price
▼
Sentiment Gauge
1
Bull
0
Bear
0
Watch
Bull 100%
Bear 0%
Price & Sentiment
Loading chart...
Recent News
Top Views ▼
No recent news for PALI
No theses available
Feed
14:06
Apr 13
Apr 13
Buy PALI to exploit a relative value inefficiency, as competitors are gaining multiples of PALI's entire market cap based on inferior open-label clinical data.
MED
About PALI Analyst Coverage
Buzzberg tracks PALI (Palisade Bio, Inc. Common Stock) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.